Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled, Crossover Study of the Safety and Efficacy of Tropicamide 1 mg Intra-oral Slow Dissolving Muco-adhesive Thin Films to Reduce Hypersalivation in PD Patients Manifesting Sialorrhea Complaints
Conditions
Interventions
NH004 tropicamide
NH004 Placebo
Locations
3
France
Hôpital de la Salpêtrière
Paris, Cedrex 13, France
Hôpital Paul de Viguier
Toulouse, Cedrex 9, France
Hôpital Haut Lévêque
Bordeaux, Pessac, France
Start Date
April 1, 2013
Primary Completion Date
October 1, 2015
Completion Date
December 1, 2015
Last Updated
December 10, 2015
Lead Sponsor
NeuroHealing Pharmaceuticals Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions